Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microvascular Responses to Cyclosporine in Dry Eye
NCT05131152Unknown
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Dec 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of cyclosporine 2% ophthalmic solution in dry eye syndrome (DED) (2 arms), sponsored by Zhongshan Ophthalmic Center. Primary endpoint: Conjunctival microvascular blood flow velocity at 16 weeks. Status: unknown.
02
Drugs
cyclosporine 2% ophthalmic solution
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT05131152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05131152.